VET.TO stock rose 6.76% intraday to C$15.64 on 03 Mar 2026 as traders priced in Q4 2025 results due 04 Mar 2026. Volume ran at 1,927,808 shares versus an average of 1,147,032, signalling heavier interest ahead of the report. Investors will watch production metrics, commodity pricing sensitivity, and the company’s dividend guidance for catalysts that could drive the next move.

VET.TO stock intraday price action and volume

Vermilion Energy Inc. (VET.TO) traded between C$15.29 and C$16.15 today, hitting a near 52-week high versus a year low of C$7.29. The intraday gap higher followed an open at C$16.00 and a previous close of C$14.65, showing a one-day change of C$0.99. Trading ran at roughly 2.04x relative volume, which often precedes earnings-driven re-rating when flows concentrate.

VET.TO stock earnings setup: what to watch in Q4

Vermilion reports Q4 results on 04 Mar 2026 and the market will focus on production, realized oil and gas prices, and free cash flow. Expectations frame EPS near C$0.67 and management commentary on capex and dividend sustainability will matter. A stronger cash-flow print would support the current dividend yield near 3.35% and could prompt upward revisions.

VET.TO stock fundamentals and valuation

Vermilion shows a market cap near C$2.38B and key ratios include a P/E of 23.18, price-to-book of 0.88, EV/EBITDA of 3.82, and free cash flow yield around 15.67%. The company reports book value per share of C$17.55 and a dividend per share of C$0.52. These metrics point to value-style characteristics within the TSX energy complex.

Meyka AI rates VET.TO with a score out of 100 and technical snapshot

Meyka AI rates VET.TO with a score out of 100 at 65.59 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technicals show an RSI of 72.80 (overbought) and an ADX of 31.18, indicating a strong short-term trend but stretched momentum. Traders should weigh strength against potential post-earnings mean-reversion risk.

VET.TO stock analyst targets and Meyka price view

Street targets range from C$13.00 to C$18.50, with a MarketBeat consensus near C$14.50 and recent broker upgrades from National Bank Financial to C$18.50. For clarity, we present scenario price targets: conservative C$13.00, base C$15.00, and bull C$18.50. These reflect varying oil price and production assumptions and compare to the current price of C$15.64 on the TSX in CAD.

VET.TO stock risks and opportunities ahead of the report

Key risks include weaker-than-expected realized prices, production shortfalls in Europe or Australia, and higher-than-expected capex. Opportunities include stronger oil/NGL pricing, improved cost guidance, and higher free cash flow that could support buybacks or dividend increases. Short interest headlines and insider activity should be monitored as potential volatility drivers.

Final Thoughts

Key takeaways: VET.TO stock is running up into earnings with heavier volume and a near-term technical overbought reading. Analysts show mixed targets from C$13.00 to C$18.50, and the stock trades at a P/E of 23.18 and a price-to-book of 0.88 on the TSX in Canada. Meyka AI’s forecast model projects a near-term reference of C$11.29 (monthly model) and a yearly projection of C$5.60. Versus the current price of C$15.64, the monthly projection implies a -27.79% move and the yearly projection implies a -64.18% move; forecasts are model-based projections and not guarantees. Monitor Q4 production, realized pricing, and free cash flow as the primary earnings levers. For our view, a beat on cash flow with improved guidance would support the C$15.00–C$18.50 range, while a weak print could test C$12.00. Meyka AI provides this analysis as an AI-powered market analysis platform; this is informational and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.